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Although several lines of evidence suggest that the glycosyl phosphatidylinositol-anchored 
cell surface protein Sca-1 marks cardiac-resident stem cells, a critical analysis of the 
literature raises some concerns regarding their cardiomyogenic potential.1 Here, isolated 
adult cardiac-resident Sca-1+ cells were engrafted into infarcted hearts and monitored for 
cardiomyogenic differentiation. Donor cells were prepared from ACT-EGFP; MHC-nLAC 
double-transgenic mice ([C57/Bl6J x DBA/2J]F1 genetic background; all procedures 
followed were in accordance with Institutional Guidelines). The ACT-EGFP transgene 
targets ubiquitous expression of an enhanced green fluorescent protein reporter, and the 
MHC-nLAC transgene targets cardiomyocyte-restricted expression of a nuclear-localized β-
galactosidase reporter. Donor cell survival was monitored via EGFP fluorescence, while 
cardiomyogenic differentiation was monitored by reacting with the chromogenic β-
galactosidase substrate 5-bromo-4-chloro-3-indolyl-β-D-galactoside (X-GAL), which gives 
rise to a blue product.2 Double-transgenic hearts were dispersed with Blendzyme and the 
resulting cells reacted with an APC-conjugated anti-Sca-1 antibody and a PE-conjugated 
cocktail of antibodies recognizing hematopoietic lineage markers.3 Sca-1+, EGFP+, lineage- 
cells were then isolated via fluorescence-activated cell sorting (FACS; characterization of the 
donor cells is provided in Figure 1A), and 100,000 cells were injected into the infarct border 
zone of non-transgenic [C57/Bl6J x DBA/2J]F1 mice immediately following permanent 
coronary artery occlusion.
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To screen for cardiomyogenic activity, hearts were harvested at 11 (n=3), 12 (n=3), 14 (n=2) 
or 21 (n=2) days post-engraftment, fixed and sectioned on a vibratome at 200 microns; 
sections were then reacted with X-GAL and visualized on a dissecting microscope. No 
nuclear β-galactosidase activity was detected (Figure 1B), despite the presence of Sca-1+ 
donor cells as evidenced by the presence of EGFP fluorescence (inset). To confirm the 
absence of cardiomyogenic differentiation, all vibratome sections exhibiting EGFP 
fluorescence were cryosectioned at 10 microns and analyzed (example shown in Figure 1C). 
No nuclear β-galactosidase activity was observed (8,577 EGFP+ cells analyzed, the 
engraftment efficiency was 0.87%). Immune cytology confirmed that the green fluorescent 
signal co-localized with EGFP protein (not shown). As a positive control for the reporter 
system, cardiomyocytes prepared from embryonic day 15.5 ACT-EGFP; MHC-nLAC 
double transgenic mice were engrafted into the hearts of syngeneic [C57/Bl6J x DBA/2J]F1 
recipients; the hearts were harvested at 14 days post-engraftment and processed exactly as 
described above. Donor cells with nuclear β-galactosidase activity and EGFP fluorescence 
were readily observed in the engrafted hearts (Figure 1D). Immune histology revealed that at 
least a portion of the Sca-1+ donor cells express vimentin (Figure 1E), suggesting that they 
may give rise to fibroblast-like cells when engrafted into injured hearts.
Prior to fixation, all of the hearts analyzed above were screened for the presence of 
intracellular calcium ([Ca2+]i) transients in engrafted Sca-1+ cells. To accomplish this, hearts 
were perfused with cytochalasin D (to effect excitation/contraction un-coupling) and loaded 
with rhod-2 (an indicator dye which exhibits increased fluorescence with increased [Ca2+]i). 
The hearts were imaged via two-photon laser scanning microscopy to monitor the presence 
of EGFP and rhod-2 fluorescence.4 Donor Sca-1+, EGFP+, lineage- cells were readily 
detected via two-photon laser scanning microscopy due to their EGFP fluorescence (Figure 
1F, left panel). Integrated traces of line-scan signals revealed the absence of transient 
increases in rhod-2 fluorescence, indicative of the absence of stimulation-evoked increases 
in [Ca2+]i (Figure 1F, right panel; 370 EGFP+ cells analyzed, n=5 hearts analyzed at 11 
(n=3), 12 (n=1) and 21 (n=1) days post-engraftment). In contrast, transient changes in 
rhod-2 fluorescence, indicative of [Ca2+]i transients, were observed in engrafted EGFP-
expressing fetal cardiomyocytes (Figure 1G, full-frame image on the left, integrated traces 
of rhod-2 fluorescence on the right). Collectively these data indicate that the engrafted 
Sca-1+, EGFP+, lineage- cells failed to undergo cardiomyogenic differentiation.
Although EGFP fluorescence is widespread in ACT-EGFP mice, expression is not 100% 
penetrant. To rule out the possibility that the reporter failed to mark cardiomyogenic 
progenitors, Sca-1+, lineage- donor cells were isolated via FACS (i.e., sorting independently 
of EGFP expression) from double-transgenic mice, and 100,000 cells were transplanted into 
the infarct border zone immediately following permanent coronary artery occlusion. No 
cardiomyogenic events, as evidenced by the lack of nuclear β-galactosidase activity, were 
detected at 14 days post-engraftment (Figure 1H; 9,319 EGFP+ cells were present in the 
sections analyzed, n=3 engrafted hearts; the engraftment efficiency was 3.1%). Although 
unlikely, the process of FACS enrichment may have selectively eliminated cells with 
cardiomyogenic potential. Accordingly, Sca-1+ cells from ACT-EGFP; MHC-nLAC double 
transgenic animals were isolated via magnetic-activated cell sorting5 and transplanted into 
the infarct border zone. Once again, cells with robust EGFP fluorescence were detected in 
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the engrafted hearts (analyzed at 14 (n=13) or 21 (n=4) days post-engraftment), indicating 
donor cell survival. However, no cardiomyogenic events were detected (70,166 EGFP+ cells 
analyzed, n=17 engrafted hearts, the engraftment efficiency was 4.2%).
In total, no cardiomyogenic events were detected when 88,062 EGFP+ donor cells were 
analyzed amongst 30 engrafted hearts between 11 and 21 days post-engraftment; thus, adult 
cardiac-resident cells expressing the cell surface marker Sca-1 appear to lack 
cardiomyogenic activity.
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Figure 1. 
Adult cardiac-resident Sca-1+ cells fail to undergo cardiomyogenic differentiation following 
engraftment into infarcted mouse hearts. (A) FACS characterization of donor Sca-1+, EGFP
+
, lineage- donor cells isolated from adult ACT-EGFP; MHC-nLAC double-transgenic mice 
prior to engraftment. (B) Bright field image of a vibratome section from an infarcted heart 
engrafted with Sca-1+, EGFP+, lineage- cells isolated from ACT-EGFP; MHC-nLAC 
double-transgenic donors (the section was reacted with X-GAL). Arrow indicates the 
position of the infarct and the inset shows a fluorescent view of the engrafted region (box) at 
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higher magnification. The example shown is at 14 days post-engraftment. (C) EGFP 
fluorescence (left panel), bright field (center panel) and Hoechst fluorescence (right panel) 
views of a 10 micron cryosection prepared from a vibratome section of a heart engrafted 
with Sca-1+, EGFP+, lineage- cells (the vibratome section was reacted with X-GAL). The 
donor cell nuclei (arrows) do not react with X-GAL. The example shown is at 11 days post-
engraftment. (D) Bright field (left panel) and EGFP fluorescence (right panel) views of a 10 
micron cryosection prepared from a vibratome section of an infarcted heart engrafted with 
embryonic cardiomyocytes from ACT-EGFP; MHC-nLAC double-transgenic donors (the 
vibratome section was reacted with X-GAL; please note that the X-GAL reaction product 
blocks visualization of EGFP and Hoechst fluorescence). The example shown is at 14 days 
post-engraftment. (E) Color combined fluorescence view of vimentin immune reactivity (red 
signal) and EGFP (green) in an infarcted heart engrafted with Sca-1+, EGFP+, lineage- donor 
cells. Yellow signal (arrows) indicates that some of the donor cells are adopting a fibroblast-
like phenotype. The example shown is at 11 days post-engraftment. (F & G) In situ imaging 
of [Ca2+]i transients from an infarcted heart engrafted with adult Sca-1+, EGFP+, lineage- 
donor cells (F) or fetal cardiomyocytes from double-transgenic ACT-EGFP; MHC-nLAC 
transgenic mice (G). In each case, the left panels show the full-frame two-photon laser 
scanning image of the analyzed cells, while the right panels show the integrated traces of 
rhod-2 (red lines) fluorescence collected in line-scan mode; the white dotted lines indicate 
the positions where the integrated traces were recorded. The examples shown are at 11 days 
post-engraftment. The in situ imaging protocol has been described previously.4 Briefly, 
Langendorff-perfused hearts were loaded with the fluorescent calcium indicator rhod-2 
using the cell membrane permeable AM-ester of the dye (10 μmol/L rhod-2-AM for 10 
min.). Hearts were illuminated (810 nm using a mode-locked Ti:sapphire laser) and imaged 
with a Bio-Rad MRC 1024 laser scanning microscope; emitted light was collected at 560–
650 nm and 500–550 nm). In all cases the hearts were subjected to electrical field 
stimulation to ensure donor cell membrane depolarization during imaging. For full-frame 
mode, lines were scanned at 1.46 and 0.73 frames per second on horizontal (x, y) planes. For 
line-scan mode, lines were scanned at 500 Hz and images (x, t) were constructed by stacking 
all lines vertically. (H) EGFP fluorescence (left panel), bright field (center panel) and 
Hoechst fluorescence (right panel) views of a 10 micron cryosection prepared from a 
vibratome section of a heart engrafted with Sca-1, lineage- cells from ACT-EGFP; MHC-
nLAC double-transgenic donors sorted independently of EGFP expression (the vibratome 
section was reacted with X-GAL). The donor cell nuclei do not react with X-GAL. Example 
shown is at 14 days post-engraftment.
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